Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Current-Deferred-Revenue" stands at 2.60 Billion Swiss Francs as of 06/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.98 Billion Swiss Francs compared to the value the year prior.
The 1 year change is -0.98 Billion Swiss Francs.
The 3 year change is -0.877 Billion Swiss Francs.
The 5 year change is 6.77 Billion Swiss Francs.
The 10 year change is 6.98 Billion Swiss Francs.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |
![]() | Novartis AG - Current Deferred Revenue | 255,096,620,580.91 |